The N-terminal end of the C(H)2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, FcγRI and FcγRIII binding

Immunology

Volumn 86, Issue 2, 1995, Pages 319-324

  Morgan, A ^a   Jones, N D ^a   Nesbitt, A M ^a   Chaplin, L ^a   Bodmer, M W ^a   Emtage, J S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; FC RECEPTOR; HLA DR ANTIGEN; IMMUNOGLOBULIN G1;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; COMPLEMENT ACTIVATION; CYTOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

AMINO ACIDS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGEN-ANTIBODY REACTIONS; BINDING SITES, ANTIBODY; CHIMERIC PROTEINS; COMPLEMENT 1Q; COMPLEMENT ACTIVATION; HLA-DR ANTIGENS; HUMAN; IMMUNOGLOBULIN CONSTANT REGION; IMMUNOGLOBULIN G; RECEPTORS, IGG; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0028970836     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)